You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

711 Results
Document
Mar 2018
Guidelines and Advice
Status: In-Review
ID: 6-13
Mar 2018
Document
Apr 2018
Document
Apr 2018
Document
Apr 2018
Document
Apr 2018
Drug
Other Name(s): Oncaspar®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2022
Guidelines and Advice
Status: Current
Version: 2
May 2021
Guidelines and Advice
Status: Current
ID: PET 2017-2
Version: n/a
May 2018
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
pemetrexed
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2023
Document
Jul 2018
Guidelines and Advice
Status: Current
Version: 1
Jun 2018

Pages